George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Y-Alam. Feel free to post some scientific research/ articles et al to back this comment up.
People have had more than enough patience. The reason for radio silence from last few months is quite apparent how many other contracts have been effected - ' similar delays from other prospects as a result of the second wave of COVID-19 '
Will re buy when matters settle down.
It would be worthwhile the company putting a general RNS update out to clarify new shareholder register.
for a bit of xmas cheer.
Yes it is looking strong atm. Long may it continue.
Agreed. PI's sick of the company's nonsense, Fowler will have to try a lot harder than that RNS.
Strange old stock. Lots of willing sellers at any movement, even at lows, suggests some legacy sellers and traders.
PI's think - SP didn't move as much as i expected and give me a quick buck . So what i do now - sell? Lol
The expectation and need for immediate reward feeds the mm. Notification of holdings will arrive. This may revisit the 30's , but I for one will be buying. Research and understand of what you are investing in isessential.
Shaping up to be an extensive field.
Could be very material in the post covid world.
spurt in SP and more interestingly, volume. Update due?
from the company would be most welcome at the moment.
Yep looks a good appointment. Seems the new bod is now in place. Also see three of them are now in Glycotest. More patience here but they clearly are putting the building blocks in place, see how it unfolds in coming months.
Appointment of John Clarkson as Executive Chairman of NetScientific (from his previous position as Non-Executive Chairman), as Chairman of NetScientific subsidiary ProAxsis, and as a Director of Glycotest.
How about an update on Glycotest?
perhaps 7am would have done it more justice. Nice tech and green credentials
http://www.sagetechmedical.com/the-problem/
more posts than trades today, sums up the doldrums that nsci is in.
Have a few bob invested here, and would put more in if, and it is a big if, the BoD were somewhat more proactive and aligned with their investors. Glycotest was my main interest, but the lack of an update is worrying. Time for the BoD to deliver some news and interest.
will wait for the eager £5005 seller to finish (£45k thus far today)
Yep, on paper some good investments. lack of regular newsflow kills sentiment, that said, if Glycotest is positive (and it is very overdue) then this moves expeditiously.